GLP-3 RT10 — 10mg Research Vial
LY3437943
$55.00
GLP-3 RT10 is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, currently under active Phase 3 clinical investigation. Among the most studied compounds in contemporary metabolic and energy homeostasis research. Supplied as a lyophilized powder in a 3mL multi-dose vial. Purity ≥99% by HPLC. COA from an independent, accredited laboratory included with every order. For research use only. Not for human consumption.
Out of stock
Currently unavailable — pending Certificate of Analysis (COA). This compound will be available for order once third-party lab verification is complete.
| Molecular weight | 4,786 Da |
|---|---|
| Sequence origin | Synthetic / Eli Lilly pipeline (Phase 3) |
| Primary pathways | GLP-1R, GIPR, GcgR (triple agonist) |
| Solubility | 0.9% NaCl or bacteriostatic water |
| Storage (lyophilized) | Storage (Lyophilized): |
| Storage (in solution) | 4°C; use within 28 days of reconstitution |
| Preclinical research areas | Incretin receptor signaling, metabolic homeostasis models, insulin secretion assays, energy expenditure studies |
For research use only. Not for human or veterinary use. Certificate of analysis available upon request.